VEGF expression in adult permanent thyroid cartilage: Implications for lack of cartilage ossification

Bone

Volumn 35, Issue 2, 2004, Pages 543-552

  Pufe, Thomas ^a   Mentlein, Rolf ^a   Tsokos, Michael ^b   Steven, Philipp ^a   Varoga, Deike ^a,c   Goldring, Mary B ^d   Tillmann, Bernhard N ^a   Paulsen, Friedrich P ^a,e  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d HARVARD INSTITUTES OF MEDICINE   (United States)

^e MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Angiogenesis; Chondrocyte; Endostatin; Permanent cartilage; reverse transcriptase polymerase chain reaction; RT PCR; vascular endothelial growth factor; vascular endothelial growth factor receptor; VEGF; VEGFR

Indexed keywords

ENDOSTATIN; PROTEIN TYROSINE KINASE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ARTICLE; CARTILAGE CELL; CONCENTRATION (PARAMETERS); DOWN REGULATION; EMBRYOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GROWTH PLATE; HUMAN; HUMAN TISSUE; HYPERTROPHY; IMMUNOHISTOCHEMISTRY; LARYNX CARTILAGE; MALE; OSSIFICATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BASE SEQUENCE; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; OSTEOGENESIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYROID CARTILAGE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 3242706026     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2004.02.026     Document Type: Article

References (37)

1. Gilbert S.F. Developmental biology. Fifth ed.:1997;Sinauer Associates, Sunderland, MA
2. Knese K.H. Stützgewebe und Skelettsystem. Möllendorf Wv., Bargmann W. Handbuch der mikroskopischen Anatomie des Menschen, Bd 2. Die Gewebe, Teil 5, 4.2. Der hyaline Epiphysenknorpel im Vergleich mit anderen hyalinen Knorpeln. 1979;272-284 Springer, Heidelberg, Germany
3. Pacifici M. Tenascin-C and the development of articular chondrocytes. Exp. Cell Res. 192:1995;266-270
4. Neufeld G., Cohen T., Gengrinovitch S., Poltrak Z. Vascular endothelial growth factor and its receptors. FASEB J. 13:1999;9-22
5. Gerber H.P., Vu T.H., Ryan A.M., Kolwalski J., Werb Z., Ferrara N. VEGF couples hypertrophic cartilage remodelling, ossification and angiogenesis during endochondral bone formation. Nat. Med. 5:1999;623-628
6. Horner A., Bishop N.J., Bord S., Beeton C., Kelsall A.W., Coleman N., et al. Immunolocalisation of vascular endothelial growth factor (VEGF) in human neonatal growth plate cartilage. J. Anat. 194:1999;519-524
7. Carlevaro M.F., Cermelli S., Cancedda R., Descalzi-Cancedda F. Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation. J. Cell Sci. 113:2000;59-69
8. Garcia-Ramirez M., Toran N., Andaluz P., Carrascosca A., Audi L. Vascular endothelial growth factor is expressed in human fetal growth cartilage. J. Bone Miner. Res. 15:2000;534-540
9. O'Reilly M.S., Boehm T., Shing Y., Fukai N., Vasios G., Lane W.S., et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell. 88:1997;277-285
10. Eckhart L., Ban J., Ballaun C., Weniger W., Tschachler E. Reverse transcription-polymerase chain reaction products of alternatively spliced mRNAs form heteroduplexes and heteroduplex complexes. J. Biol. Chem. 274:1999;2613-2615
11. 189 of the angiogenetic peptide vascular endothelial growth factor are expressed in osteoarthritic cartilage. Arthritis Rheum. 44:2001;1082-1088
12. Tillmann B., Wustrow F., Kehlkopf I. Berendes J. Hals-Nasen-Ohren- Heilkunde in Praxis und Klinik 4/1. 1982;1.6-1.7 Thieme, Stuttgart, Germany
13. Jakeman L.B., Armanini M., Phillips H.S., Ferrara N. Developmental expression of binding sites and messenger ribonucleic acid for vascular endothelial growth factor VEGF suggests a role for this protein in vasculaogenesis and angiogenesis. Endocrinology. 133:1993;848-859
14. Flamme I., von Reutern M., Drexler H.C.A., Syed-Ali K., Risau W. Overexpression of vascular endothelial growth factor in the avian embryo induces hypervascularization and increase vascular permeability without alterations of embryonic pattern formation. Dev. Biol. 171:1995;399-414
15. Schmidt M., Flamme I. The in vivo activity of vascular endothelial growth factor isoforms in the avian embryo. Growth Factors. 15:1998;183-197
16. Ferrara N. The biology of VEGF and its receptors. Nat. Med. 9:2003;669-676
17. Pinney E., Liu K., Sheeman B., Mansbridge J. Human three-dimensional fibroblast cultures express angiogenic activity. J. Cell. Physiol. 183:2000;74-82
18. Inoki I., Shiomi T., Hashimoto G., Enomoto H., Nakamura H., Makino K.I., et al. Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. FASEB J. 16:2002;219-221
19. Gerber H.P., Malik A.K., Solar G.P., Sherman D., Liang S.H., Meng G., et al. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature. 27:2002;954-958
20. Chievitz J.H. Untersuchungen über die Verknöcherung der menschlichen Kehlkopfknorpel. Arch. Anat. Physiol. Anat. Abt. 1:1882;303-349
21. Levine A.C., Liu X.H., Greenberg P.D., Eliashvili M., Schiff J.D., Aaronson S.A., et al. Androgens induce the expression of vascular endothelial growth factor in human fetal prostatic fibroblasts. Endocrinology. 139:1998;4672-4678
22. Miyamoto N., Mandai M., Takagi H., Suzuma I., Suzuma K., Koyama S., et al. Contrasting effect of estrogen on VEGF induction under different oxygen status and its role in murine ROP. Invest. Ophthalmol. Visual Sci. 43:2002;2007-2014
23. Pascher M. Zur Kenntnis der Altersveränderungen in den menschlichen Kehlkopfknorpeln, insbesondere der körnigen Entartung der Knorpelgrund-substanz, der Vascullarisations-, Resorptions-und Verknöcherungsbefunde. Virchows Arch. Pathol. Anat. Physiol. Klin. Med. 246:1923;198-238
24. Claassen H., Kirsch T., Simons G. Cartilage canals in human thyroid cartilage characterized by immunolocalization of collagen types I, II, pro-III, IV and X. Anat. Embryol. 194:1996;147-153
25. Iwamoto M., Sato K., Nakashima K., Shimazu A., Kato Y. Hypertrophy and calcification of rabbit permanent chondrocytes in eluted cultures: synthesis of alkaline phosphatase and 1,25-dihydroxycholecalciferol receptor. Dev. Biol. 136:1989;500-507
26. Pacifici M., Iwamoto M., Golden E.B., Leatherman J.L., Lee Y.S., Chuong C.M. Tenascin is associated with articular cartilage development. Dev. Dyn. 198:1991;123-134
27. Stephens M., Kwan A.P., Bayliss M.T., Archer C.W. Human articular surface chondrcytes initiate alkaline phosphatase and type X collagen synthesis in suspension culture. J. Cell Sci. 103:1992;1111-1116
28. Ueta C., Iwamoto M., Kanatani N., Yoshida C., Liu Y., Enomoto-Iwamoto M., et al. Skeletal malformations caused by overexpression of Cbfa1 or its dominant negative form in chondrocytes. J. Cell Biol. 153:2001;87-99
29. Pfander D., Kortje D., Zimmermann R., Weseloh G., Kirsch T., Gesslein M., et al. Vascular endothelial growth factor in articular cartilage of healthy and osteoarthritic human knee joints. Ann. Rheum. Dis. 60:2001;1070-1073
30. Matyas J.R., Adams M.E., Huang D., Sandell L.J. Discoordinate gene expression of aggrecan and type II collagen in experimental osteoarthritis. Arthritis Rheum. 38:1995;420-425
31. von der Mark K., Kirsch T., Nerlich A., Kuss A., Weseloh G., Gluckert K., et al. Type X collagen synthesis in human osteoarthritic cartilage. Indication of chondrocyte hypertrophy. Arthritis Rheum. 35:1992;806-811
32. Pullig O., Weseloh G., Gauer S., Swoboda B. Osteopontin is expressed by adult human osteoarthritic chondrocytes: protein and mRNA analysis of normal and osteoarthritic cartilage. Matrix Biol. 19:2000;245-255
33. Shlopov B.V., Lie W.R., Mainardi C.L., Cole A.A., Chubinskaya S., Hasty K.A. Osteoarthritic lesions: involvement of three different collagenases. Arthritis Rheum. 40:1997;2065-2074
34. Hashimoto G., Inoki I., Gujii Y., Aoki T., Ikeda E., Okada Y. Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165. J. Biol. Chem. 277:2002;36288-36295
35. Moses M.A., Wiederschain D., Wu I., Fernandez C.A., Ghazizadeh V., Lane W.S., et al. Troponin I is present in human cartilage and inhibits angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 96:1999;2645-2650
36. Shukunami C., Hiraki Y. Role of cartilage-derived anti-angiogenic factor, chondromodulin I during endochondral bone formation. Osteoarthr. Cartil. 9(Suppl. A):2001;91-101
37. Kim Y.M., Hwang S., Kim Y.M., Pyun B.J., Kim T.Y., Lee S.T., et al. Endostatin blocks vascular endothelial growth factor-mediated signalling via direct interaction with KDR/Flk-1. J. Biol. Chem. 277:2002;27872-27879